Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 239S · 10 late239 trades$59.22M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 36 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $1.34M 16.1K sh | Mar 19, 2026 |
| 36 | Hope H Melville IiiCFO and Treasurer |  FWRGFirst Watch Restaurant Group, Inc.Open-market sale | SELL | $49K 3,878 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 36 | Hartman Eric RichardChief Development Officer | FWRGFirst Watch Restaurant Group, Inc. Open-market sale | SELL | $23K 1,819 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 36 | Wolszczak Jay AnthonyChief Legal Officer, GC & Secy | FWRGFirst Watch Restaurant Group, Inc. Open-market sale | SELL | $40K 3,161 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 36 | Allan JonathanGENERAL COUNSEL & CORP SEC |  STOKStoke Therapeutics, Inc.Open-market sale | SELL | $81K 2,476 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 36 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $132K 4,222 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 36 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $60K 1,791 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 35 | Neervannan SeshadriChief Operating Officer |  TARSTarsus Pharmaceuticals, Inc.Open-market sale | SELL | $248K 3,610 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 35 | Eifler Robert W.Director, President & CEO |  NENoble Corp plcOpen-market sale | SELL | $1.28M 27.2K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 33 | Sfadia AdiCEO |  GILTGILAT SATELLITE NETWORKS LTDOpen-market sale | SELL | $67K 3,978 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 33 | Robbins Edward Hutchinson Jr.EVP, General Counsel |  TLSTELOS CORPOpen-market sale | SELL | $149K 37.1K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 32 | Navratil TomasCHIEF DEVELOPMENT OFFICER |  GKOSGLAUKOS CorpOpen-market sale | SELL | $45K 460 sh | Mar 19, 2026 traded Mar 16, 2026 |
| 32 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale | SELL | $27K 272 sh | Mar 19, 2026 traded Mar 16, 2026 |
| 32 | Navratil TomasCHIEF DEVELOPMENT OFFICER | GKOSGLAUKOS Corp Open-market sale | SELL | $29K 299 sh | Mar 19, 2026 traded Mar 16, 2026 |
| 32 | Leggett ThomasChief Financial Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $5,468 172 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Leggett ThomasChief Financial Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $1,215 37 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Coffin KimSVP, Chief Forager |  SFMSprouts Farmers Market, Inc.Open-market sale | SELL | $39K 467 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Hurley Joseph LChief Supply Chain Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $38K 456 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $26K 379 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Robbins Edward Hutchinson Jr.EVP, General Counsel | TLSTELOS CORP Open-market sale | SELL | $259K 64.5K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Zalatoris TimmiChief Human Resources Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $49K 585 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 32 | Jones Stephen FrancisDirector |  WLFCWILLIS LEASE FINANCE CORPOpen-market sale | SELL | $98K 587 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 32 | Hoitt JasonChief Patient Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $4,419 139 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Hoitt JasonChief Patient Officer | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $986 30 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Zalatoris TimmiChief Human Resources Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $40K 480 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Valentine CurtisChief Financial Officer | SFMSprouts Farmers Market, Inc. Open-market sale | SELL | $15K 183 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 32 | Lin Elizabeth YeuChief Medical Officer | TARSTarsus Pharmaceuticals, Inc. Open-market sale | SELL | $26K 390 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 29 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $2,365 72 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 29 | Allan JonathanGENERAL COUNSEL & CORP SEC | STOKStoke Therapeutics, Inc. Open-market sale | SELL | $11K 334 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 29 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $711K 8,666 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 28 | Liegel Matthew AChief Accounting Officer |  TGTTARGET CORPOpen-market sale | SELL | $241K 2,053 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 28 | Reed Marcy L.Director |  CLHCLEAN HARBORS INCOpen-market sale | SELL | $241K 836 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | von Heynitz HaraldDirector |  FLNCFluence Energy, Inc.Open-market sale | SELL | $165K 10.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 28 | Wills Phillip R. IIIDirector |  FVCBFVCBankcorp, Inc.Open-market sale | SELL | $170K 11.5K sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Geller AdamChief Product Officer |  ZSZscaler, Inc.Open-market sale · 10b5-1 plan | SELL | $233K 1,485 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Vanderhook TimothyDirector, CEO and Chairman, 10% Owner |  DSPViant Technology Inc.Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Agrawal NitinChief Financial Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $25K 300 sh | Mar 19, 2026 traded Mar 17, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $180K 15.0K sh | Mar 19, 2026 traded Mar 18, 2026 |
| 23 | Capital V LLC10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $100K 8,760 sh | Mar 19, 2026 traded Mar 19, 2026 |
| 23 | Vanderhook ChristopherDirector, Chief Operating Officer, 10% Owner | DSPViant Technology Inc. Open-market sale · 10b5-1 plan | SELL | $60K 5,000 sh | Mar 19, 2026 traded Mar 18, 2026 |
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
ADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
ARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K